TY - JOUR
T1 - 3D Bioprinting
T2 - from Benches to Translational Applications
AU - Heinrich, Marcel Alexander
AU - Liu, Wanjun
AU - Jimenez, Andrea
AU - Yang, Jingzhou
AU - Akpek, Ali
AU - Liu, Xiao
AU - Pi, Qingmeng
AU - Mu, Xuan
AU - Hu, Ning
AU - Schiffelers, Raymond Michel
AU - Prakash, Jai
AU - Xie, Jingwei
AU - Zhang, Yu Shrike
PY - 2019/6/7
Y1 - 2019/6/7
N2 - Over the last decades, the fabrication of 3D tissues has become commonplace in tissue engineering and regenerative medicine. However, conventional 3D biofabrication techniques such as scaffolding, microengineering, and fiber and cell sheet engineering are limited in their capacity to fabricate complex tissue constructs with the required precision and controllability that is needed to replicate biologically relevant tissues. To this end, 3D bioprinting offers great versatility to fabricate biomimetic, volumetric tissues that are structurally and functionally relevant. It enables precise control of the composition, spatial distribution, and architecture of resulting constructs facilitating the recapitulation of the delicate shapes and structures of targeted organs and tissues. This Review systematically covers the history of bioprinting and the most recent advances in instrumentation and methods. It then focuses on the requirements for bioinks and cells to achieve optimal fabrication of biomimetic constructs. Next, emerging evolutions and future directions of bioprinting are discussed, such as freeform, high-resolution, multimaterial, and 4D bioprinting. Finally, the translational potential of bioprinting and bioprinted tissues of various categories are presented and the Review is concluded by exemplifying commercially available bioprinting platforms.
AB - Over the last decades, the fabrication of 3D tissues has become commonplace in tissue engineering and regenerative medicine. However, conventional 3D biofabrication techniques such as scaffolding, microengineering, and fiber and cell sheet engineering are limited in their capacity to fabricate complex tissue constructs with the required precision and controllability that is needed to replicate biologically relevant tissues. To this end, 3D bioprinting offers great versatility to fabricate biomimetic, volumetric tissues that are structurally and functionally relevant. It enables precise control of the composition, spatial distribution, and architecture of resulting constructs facilitating the recapitulation of the delicate shapes and structures of targeted organs and tissues. This Review systematically covers the history of bioprinting and the most recent advances in instrumentation and methods. It then focuses on the requirements for bioinks and cells to achieve optimal fabrication of biomimetic constructs. Next, emerging evolutions and future directions of bioprinting are discussed, such as freeform, high-resolution, multimaterial, and 4D bioprinting. Finally, the translational potential of bioprinting and bioprinted tissues of various categories are presented and the Review is concluded by exemplifying commercially available bioprinting platforms.
KW - 3D bioprinting
KW - additive manufacturing
KW - bioinks
KW - regenerative medicine
KW - tissue engineering
KW - 22/4 OA procedure
UR - http://www.scopus.com/inward/record.url?scp=85065211213&partnerID=8YFLogxK
U2 - 10.1002/smll.201805510
DO - 10.1002/smll.201805510
M3 - Review article
C2 - 31033203
AN - SCOPUS:85065211213
SN - 1613-6810
VL - 15
JO - Small
JF - Small
IS - 23
M1 - 1805510
ER -